Ultrasound in the management of hepatic veno-occlusive disease in three children treated with dactinomycin and vincristine

Pediatric Hematology and Oncology

Volumn 13, Issue 6, 1996, Pages 521-529

  Schiavetti, Amalia ^a   Matrunola, Marco ^a   Varrasso, Giulia ^a   Padula, Anthony ^a   Castello, Manuel A ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

children; ultrasonography; veno occlusive disease

Indexed keywords

DACTINOMYCIN; EPIRUBICIN; VINCRISTINE;

ARTICLE; ASCITES; CASE REPORT; CHILD; ECHOGRAPHY; FEMALE; FIBROMATOSIS; GALLBLADDER DISEASE; HEPATOMEGALY; HUMAN; LIVER TOXICITY; LIVER VEIN OBSTRUCTION; MALE; NEPHROBLASTOMA;

EID: 0029856918     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019609030867     Document Type: Article

References (19)

1. D'Angio GJ. Unexpected toxicity encountered in the National Wilms' Tumor Study. Cancer Treat Rep. 1987;71:993.
2. Nybonde T, Eklof O, Biörk O. Wilms' tumor complicated by veno-occlusive disease of the liver (VOD): current concepts and a case report. Pediatr Hematol Oncol. 1988;5:53-60.
3. Pritchard J, Raine J, Wallendszus K. Hepatotoxicity of actinomycin-D. Lancet. 1989;21:168.
4. Green DM, Finklestein JZ, Norkool P, et al. Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine: a report of the National Wilms' Tumor Study Group. Cancer. 1988;62:270-273.
5. Adachi N, Matsuda I. Veno-occlusive disease of the liver after combined adjuvant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of the gabexate mesylate (FOY). J Pediatr Gastroenterol Nutr. 1992;14:314-318.
6. White L, Tobias V, O'Gorman Hughes DW. Actinomycin D-induced hepatotoxicity. Pediatr Hematol Oncol. 1989;6:53-57.
7. Raine J, Bowman A, Wallendszus K. Hepatopathy-thrombocytopenia syndrome - a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Children's Cancer Study Group. J Clin Oncol. 1991;9:268-273.
8. Rollins BJ. Hepatic veno-occlusive disease. Am J Med. 1986;81:297-306.
9. Griner PF, Elbadawi A, Packman CH. Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Ann Intern Med. 1976;85:578-582.
10. D'Cruz CA, Wimmer RS, Harcke HT, et al. Veno-occlusive disease of the liver in children following chemotherapy for acute myelocytic leukemia. Cancer. 1983;52:1803-1807.
11. Callihan T, Webber B, Hayes FA, et al. Chemotherapy induced hepatic veno-occlusive disease (VOD). Proc Am Soc Clin Oncol. 1983;2:76. Abstract.
12. Asbury RF, Rosenthal SN, Descalzi ME, et al. Hepatic veno-occlusive disease due to DTIC. Cancer. 1980;45:2670-2674.
13. El Saghir NS, Hawkins KA. Hepatotoxicity following vincristine therapy. Cancer. 1984;54:2006-2008.
14. Kanwar VS, Albuquerque MLC, Ribeiro RC, et al. Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature. Med Pediatr Oncol. 1995;24:334-340.
15. Ortega JA, Donaldson S, Ivy SP, et al. Venocclusive disease (VOD) of the liver. A complication of vincristine-actinomycin-cyclophosphamide (VAC) chemotherapy for childhood rhabdomyosarcoma. A report for the Intergroup Rhabdomyosarcoma Study Group. Med Pediatr Oncol. 1995;25:315. Abstract.
16. Zoubek A, Wiesbauer P, Pracher E, et al. Veno-occlusive disease der Leber als Behandlungskomplikation bei Kindern mit Wilmstumor. Padiat Padol. 1992;27:47-50.
17. Brown BP, Abu-Yousef M, Farner R, et al. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease. AJR. 1990;154:721-724.
18. Kriegshauser JS, Charboneau JW, Letendre L. Hepatic venocclusive disease after bone-marrow transplantation: diagnosis with duplex sonography. AJR. 1988;150:289-290.
19. Arndt C, Matsumoto J, Perrault J. Mild reversible veno-occlusive disease after nonmyeloablative chemotherapy documented by ultrasound. Med Pediatr Oncol. 1984;23:286. Abstract.